文献速递产科母胎医学

高龄父亲与先天性心脏缺陷的关联:系统综述与荟萃分析

Association between advanced paternal age and congenital heart defects: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod · 2020-01-01

该系统综述与荟萃分析检索MEDLINE和EMBASE(1960-2019年),纳入9项观察性研究(共9 917 011名参与者,含34 447例先天性心脏缺陷),评估高龄父亲(≥35岁)与先天性心脏缺陷的关联。汇总分析显示,高龄父亲与先天性心脏缺陷总体风险升高相关(汇总OR 1.16,95%CI 1.07-1.25)。作者认为高龄父亲可能是先天性心脏缺陷的危险因素,但关联强度有限,作为针对性筛查标准的实用性似乎有限。

要点

  • 高龄父亲(≥35岁)与先天性心脏缺陷总体风险升高相关(汇总OR 1.16,95%CI 1.07-1.25)。
  • 在基于人群的研究和低偏倚风险研究中,效应量保持稳定。
  • 作者认为高龄父亲作为先天性心脏缺陷针对性筛查标准的实用性似乎有限。

核心结论

  • 高龄父亲与先天性心脏缺陷总体风险升高相关(汇总OR 1.16,95%CI 1.07-1.25)。
  • 作者认为高龄父亲可能是先天性心脏缺陷的危险因素,但关联强度有限,作为针对性筛查标准的实用性似乎有限。

研究设计与样本

  • 系统检索MEDLINE和EMBASE(1960-2019年),不限制语言或样本量。
  • 纳入评估父亲年龄与先天性心脏缺陷关联的观察性研究,人群可包括活产、死胎和因胎儿异常终止妊娠。
  • 纳入标准:提供OR及95%CI,或提供足够信息以按父亲年龄类别重新计算OR及95%CI;排除无对照组的研 究、综述和病例报告。
  • 由两名独立评审员筛选研究、提取数据,并使用改良Newcastle-Ottawa量表评估偏倚风险。
  • 采用随机效应荟萃分析生成粗OR的汇总估计,并在亚组中检验关联。

主要发现

  • 高龄父亲(≥35岁)与先天性心脏缺陷风险升高相关(汇总OR 1.16,95%CI 1.07-1.25)。
  • 在基于人群的研究和低偏倚风险研究中,效应量保持稳定。
  • 9项纳入研究中,5项被评为低偏倚风险;仅1项基于人群的研究专门调查了孤立性先天性心脏缺陷。

局限性

  • 现有证据无法评估基于人群研究中孤立性先天性心脏缺陷的风险。
  • 现有证据无法评估父亲年龄与特定先天性心脏缺陷风险之间的关联。
  • 现有证据无法评估调整其他危险因素(如母亲年龄)后父亲年龄与先天性心脏缺陷之间的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there an association between advanced paternal age and congenital heart defects (CHD)? SUMMARY ANSWER: Advanced paternal age is associated with a 16% increase in the overall odds of CHD. WHAT IS KNOWN ALREADY: CHD are the most common congenital malformations. Several risk factors for CHD have been identified in the literature, but the association between advanced paternal age and CHD remains unclear. STUDY DESIGN, SIZE, DURATION: We conducted a systematic literature search on MEDLINE and EMBASE (1960-2019) to identify studies assessing the association between advanced paternal age (≥35 years) and the risk of CHD, unrestrictive of language or sample size. We used a combination of Medical Subject Headings (MeSH) terms and free text words such as 'paternal age', 'paternal factors', 'father's age', 'parental age', 'heart', 'cardiac', 'cardiovascular', 'abnormalities, congenital', 'birth defects', 'congenital malformations' and 'congenital abnormalities'. PARTICIPANTS/MATERIALS, SETTING, METHODS: We included observational studies aiming at assessing the association between paternal age and CHD. The included population could be live births, fetal deaths and terminations of pregnancy for fetal anomaly. To be included, studies had to provide either odds ratios (OR) with their 95% confidence interval (CI) or sufficient information to recalculate ORs with 95% CIs per paternal age category. We excluded studies if they had no comparative group and if they were reviews or case reports. Two independent reviewers selected the studies, extracted the data and assessed risk of bias using a modified Newcastle-Ottawa Scale. We used random-effects meta-analysis to produce summary estimates of crude OR. Associations were also tested in subgroups. MAIN RESULTS AND THE ROLE OF CHANCE: Of 191 studies identified, we included nine studies in the meta-analysis (9 917 011 participants, including 34 447 CHD), including four population-based studies. Five studies were judged at low risk of bias. Only one population-based study specifically investigated isolated CHD. The risk of CHD was higher with advanced paternal age (summary OR 1.16, 95% CI, 1.07-1.25). Effect sizes were stable in population-based studies and in those with low risk of bias. LIMITATIONS AND REASONS FOR CAUTION: The available evidence did not allow to assess (i) the risk of isolated CHD in population-based studies, (ii) the association between paternal age and the risk for specific CHD and (iii) the association between paternal age and CHD after adjustment for other risk factors, such as maternal age. WIDER IMPLICATIONS OF THE FINDINGS: Our findings suggest that advanced paternal age may be a risk factor for CHD. However, because the association is modest in magnitude, its usefulness as a criterion for targeted screening for CHD seems limited. STUDY FUNDING/COMPETING INTEREST(S): None. PROSPERO REGISTRATION NUMBER: CRD42019135061.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Joinau-Zoulovits F, Bertille N, Cohen JF, et al. Association between advanced paternal age and congenital heart defects: a systematic review and meta-analysis. Hum Reprod. 2020. PMID: 32730591. doi:10.1093/humrep/deaa105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。